Search research articles
Contact Us
Filters
Showing results (881-890 of 1,023) with videos related to
Page
of 103
Sort By:
Journal of the American College of Radiology : JACR
|
November 19, 2021
ACR Appropriateness Criteria® Diffuse Lung Disease
, Stephen B Hobbs, Jonathan H Chung, et al.
Human Genetics
|
August 22, 2008
Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population
Kim W Carter, Joseph Hung, Brenda L Powell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 22, 1998
The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis
D H Albert, P E Malo, P Tapang, et al.
Breathe (Sheffield, England)
|
September 29, 2017
The Global Lung Function Initiative (GLI) Network: bringing the world's respiratory reference values together
Brendan G Cooper, Janet Stocks, Graham L Hall, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Transcripts with high distal heritability mediate genetic effects on complex metabolic traits
Anna L Tyler, J Matthew Mahoney, Mark P Keller, et al.
Biorxiv : the Preprint Server for Biology
|
January 3, 2024
Assessment of Neurovascular Uncoupling: <i>APOE</i> Status is a Key Driver of Early Metabolic and Vascular Dysfunction
Kristen Onos, Peter B Lin, Ravi S Pandey, et al.
Neurobiology of Disease
|
February 10, 2011
Ndrg1 in development and maintenance of the myelin sheath
Rosalind H M King, David Chandler, Sash Lopaticki, et al.
Nature Communications
|
July 2, 2025
Transcripts with high distal heritability mediate genetic effects on complex metabolic traits
Anna L Tyler, J Matthew Mahoney, Mark P Keller, et al.
Journal of the American College of Radiology : JACR
|
March 13, 2026
ACR Appropriateness Criteria® Staging and Follow-Up of Melanoma
, Christopher Mejias, Rustain L Morgan, et al.
Journal for Immunotherapy of Cancer
|
August 6, 2020
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance status
Joao V Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, et al.
Page
of 103
Search research articles
Search
Showing results (881-890 of 1,023) with videos related to
Sort By:
Page
of 103
Journal of the American College of Radiology : JACR
|
November 19, 2021
ACR Appropriateness Criteria® Diffuse Lung Disease
, Stephen B Hobbs, Jonathan H Chung, et al.
Human Genetics
|
August 22, 2008
Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population
Kim W Carter, Joseph Hung, Brenda L Powell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 22, 1998
The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis
D H Albert, P E Malo, P Tapang, et al.
Breathe (Sheffield, England)
|
September 29, 2017
The Global Lung Function Initiative (GLI) Network: bringing the world's respiratory reference values together
Brendan G Cooper, Janet Stocks, Graham L Hall, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Transcripts with high distal heritability mediate genetic effects on complex metabolic traits
Anna L Tyler, J Matthew Mahoney, Mark P Keller, et al.
Biorxiv : the Preprint Server for Biology
|
January 3, 2024
Assessment of Neurovascular Uncoupling: <i>APOE</i> Status is a Key Driver of Early Metabolic and Vascular Dysfunction
Kristen Onos, Peter B Lin, Ravi S Pandey, et al.
Neurobiology of Disease
|
February 10, 2011
Ndrg1 in development and maintenance of the myelin sheath
Rosalind H M King, David Chandler, Sash Lopaticki, et al.
Nature Communications
|
July 2, 2025
Transcripts with high distal heritability mediate genetic effects on complex metabolic traits
Anna L Tyler, J Matthew Mahoney, Mark P Keller, et al.
Journal of the American College of Radiology : JACR
|
March 13, 2026
ACR Appropriateness Criteria® Staging and Follow-Up of Melanoma
, Christopher Mejias, Rustain L Morgan, et al.
Journal for Immunotherapy of Cancer
|
August 6, 2020
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance status
Joao V Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, et al.
Page
of 103